Young Matthew P. 4
4 · Jazz Pharmaceuticals plc · Filed Mar 4, 2019
Insider Transaction Report
Form 4
Young Matthew P.
SVP & CFO
Transactions
- Award
Ordinary Shares
2019-02-28+12,000→ 39,967 total - Award
Incentive Stock Option (right to buy)
2019-02-28+714→ 714 totalExercise: $140.03Exp: 2029-02-27→ Ordinary Shares (714 underlying) - Award
Non-Qualified Stock Option (right to buy)
2019-02-28+29,286→ 29,286 totalExercise: $140.03Exp: 2029-02-27→ Ordinary Shares (29,286 underlying)
Footnotes (2)
- [F1]These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2019, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years.
- [F2]These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, February 28, 2019, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter.